COVID-19 pandemic will have ‘profound’ impact on philanthropy, says Bill Gates

COVID-19 pandemic will have ‘profound’ impact on philanthropy, says Bill Gates

Centre for Strategic Philanthropy: A Conversation with Badr Jafar and Bill Gates

The COVID-19 pandemic will have a “profound” impact on philanthropy through forging more active collaboration and ensuring more equitable responses, Bill Gates said in an interview with Badr Jafar (Churchill College, 1997), founding patron of the Centre for Strategic Philanthropy at Cambridge Judge Business School.

The co-founder of the Gates Foundation said the scale and urgency of the pandemic has prompted philanthropists to engage in more active collaboration, not only with businesses and government but also with each other.

As an example, he cited the COVID-19 Therapeutics Accelerator involving the Gates Foundation, Mastercard, Wellcome and the Chan Zuckerberg Initiative, founded by Priscilla Chan and Facebook CEO Mark Zuckerberg.

Gates said that philanthropists are “uniquely positioned to ensure an equitable response to a challenge, in Covid’s case to ensure that diagnostics, therapeutics and vaccines reach the billions of people who need them, at an affordable cost.

“Philanthropy is also very good at moving quickly, finding new innovations, trying out things that governments will be very slow to do or might not see, and that will give us a lot of really great tools to deal with the Covid crisis.”

Bill Gates

Regarding emerging markets, Gates said that philanthropists “are very keen to increase opportunity for young people in areas like education, health and entrepreneurship. A lot of these really innovative philanthropists are first- or second-generation wealth builders, so they are able to take the latest approaches and leapfrog and improve on practices and really set examples that governments and other philanthropists can benefit from.”

He said there is a “lot of potential” in online giving, because digital platforms have “made it easier for everyone, not just the wealthy, to give to worthy causes” – and that it is “important to think about how this retail giving complements long-term philanthropy as it will continue to grow.”

The Centre for Strategic Philanthropy was launched in June 2020, with a focus on the impact of strategic philanthropy both within and from emerging global growth markets. Founding patron Badr Jafar is CEO of Crescent Enterprises and is a member of the Advisory Board of Cambridge Judge Business School.

Contributing to the fight against COVID-19

Cambridge is working hard to ensure that the full strength of the University’s research powers and resources are used in the global fight against COVID-19. From donating PPE to frontline NHS staff to supporting research, a donation of any size to any of the areas below will help advance our work and will have a real and immediate impact.

Find out how you can help.

This article was originally published on the University of Cambridge website.

Make a gift now

Make a gift now to support Cambridge COVID–19 Research Fund by credit or debit card, or set up a direct debit:

Give online

Or, find out about other ways to give.

This opportunity is part of

covid-19 virus image
Cambridge is working hard to ensure that the full strength of the University’s research powers and resources are used in the global fight against COVID-19.

Related stories

Philanthropic giving is at the heart of the success of the Collegiate University, enabling us to make discoveries that change the world and to ensure that our students receive an unrivalled education. Cambridge owes its world-leading excellence in research and teaching to the generosity of its supporters. Our history is synonymous with a history of far-sighted benefaction, and the same is as true today as it has ever been.

decorative
Philanthropic impact story
A Cambridge-developed vaccine candidate against SARS-CoV-2 could begin clinical trials in the UK in late autumn or early next year, thanks to a £1.9million award from the UK government.
decorative
Philanthropic impact story
The University of Cambridge and Royal Papworth Hospital have secured £1.5million of funding as part of the national effort by UK immunologists to understand immune responses to SARS-CoV-2, the coronavirus that causes COVID-19.
decorative
Philanthropic impact story
Since the University of Cambridge launched its COVID-19 research fund in March, more than 250 donors have given generously to help in the fight against the novel coronavirus.
decorative
Philanthropic impact story
COVID-19 has dramatically altered our students’ university experience, radically changing the Cambridge they know and exacerbating any underlying disadvantages.
decorative
Philanthropic impact story
Researchers say faster tests helped expedite access to life-saving treatments such as organ transplants – and might make all the difference later this year.
Decorative
Philanthropic impact story
The second webinar in the series examined the numbers surrounding COVID-19 and the role that model-based knowledge can have on strategic and policy decisions.
Decorative
Philanthropic impact story
Trinity alumna Professor Sadaf Farooqi is spearheading a Cambridge-China appeal to raise £5 million for PPE and alumnus Professor Yang Xia has donated and shipped facemasks from China to Cambridge. The equipment is intended to protect NHS and Social Care staff in the East of England.
decorative
Philanthropic impact story
AI assisted COVID-19 diagnostic and prognostic tool could improve resource allocation and patient outcomes

Giving opportunities

Philanthropic giving is at the heart of the success of the Collegiate University, enabling us to make discoveries that change the world and to ensure that our students receive an unrivalled education.

Research nurse from the NIHR Clinical Research Facility processing patient samples using SAMBA machines, Addenbrooke’s Hospital
The race is on to find a vaccine against the new COVID-19 coronavirus. Your support will make a difference.
Decorative
Help support students at Cambridge experiencing hardship in this crisis and beyond.